Cysteinyl leukotriene receptor 1 (CysLT1)

Class

Leukotriene receptor antagonist

Cysteinyl leukotriene receptor 1 (CysLT1) is a cell-surface receptor that responds to a family of lipid signaling molecules called cysteinyl leukotrienes, which are produced by immune cells during allergic and inflammatory responses. When these leukotrienes bind CysLT1, they trigger contraction of airway smooth muscle, increased mucus secretion, swelling of tissue due to fluid leakage from blood vessels, and recruitment of inflammatory cells such as eosinophils. This receptor is a central node in the biological cascade that produces the hallmark features of asthma and allergic rhinitis: airway narrowing, congestion, and chronic inflammation. Blocking CysLT1 with an antagonist prevents these lipid mediators from exerting their effects, which can reduce bronchoconstriction and inflammation-driven symptoms. This mechanism is distinct from corticosteroids, which broadly suppress inflammatory gene expression, and is often used as a complementary strategy, particularly in patients whose symptoms involve a strong leukotriene-driven component. The approach broadly matters in respiratory and allergic disease because leukotriene signaling contributes to symptoms even when other inflammatory pathways are also active, making receptor blockade a useful adjunct rather than a standalone anti-inflammatory strategy in most clinical contexts.